Medicine
Tryvio 12.5 mg tablet
Tryvio 12.5 mg tablet is a prescription medicine containing Aprocitentan for oral use, marketed by Idorsia Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Aprocitentan
- Brand
- Tryvio
- Strength
- 12.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 bottle, 1 blister pack
- Marketing authorisation holder
- Idorsia Pharmaceuticals
- Manufacturer
- Idorsia Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C (59°F to 86°F). Store in the original package. Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02KN01 Aprocitentan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 March 2024
- Identifiers
- RxCUI 2679064, 2679070DailyMed set ID dfe7a2ee-612c-4aba-834a-d68e6b59a0a6NDC 80491-8012Application NDA217686
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 30 tablet, film coated in 1 bottle | 80491-8012-3 | Idorsia Pharmaceuticals | 1 October 2024 |
| 1 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 80491-8012-8 | Idorsia Pharmaceuticals | 20 March 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Aprocitentan is an endothelin receptor antagonist indicated for the treatment of hypertension, to lower blood pressure (BP) in adult patients who are not adequately controlled on other drugs. It is available as tablets for oral use. MedsAcross supplies Aprocitentan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AprocitentanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TRYVIO prescribing information (Idorsia Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Jeraygo: European public assessment report (EPAR) · European Medicines Agency
Need Tryvio 12.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.